Sertoli Leydig Cell Tumours are a group of relatively rare ovarian tumours of the sex cord stromal group occurring mostly in young girls and are usually benign and unilateral. The malignant counterpart are usually bilateral, very aggressive and have poor prognosis. Approximately half of these young women present with symptoms of virilization.  Histopathologically most of these  tumours show intermediate to poor differentiation. The degree if differentiation, tumour grading and surgical staging at  diagnosis are the most important prognostic factors. Surgery is the most important treatment modality chemotherapy with BEP regime is indicated when associated with poor prognostic factors, but controversy exists regarding the same. There exists a great need for more number of clinical studies and evidence– based data for formulating a standard treatment protocol including chemotherapy